Home › Markets › Health Care › NDRA

ENDRA Life Sciences Inc. (NDRA)

NDRA trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$5.04
-1.85% on the day
Market cap
$7.6M
Nano cap
Revenue
No annual revenue filed since the period ending 2020-12-31
Net income
No annual revenue filed since the period ending 2020-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerNDRA on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2017
SEC CIK0001681682
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials

No annual revenue filed since the period ending 2020-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B42025-11-26
Latest annual report
ANNUAL REPORT
10-K2026-03-31
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-08-14
Latest current report
CURRENT REPORT
8-K2026-10-01
Latest proxy
DEFA 14A
DEFA14A2025-10-28

Source: SEC EDGAR submissions feed, 543 recent filings. All filings on EDGAR.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
IRIXIRIDEX Corporation$0.8483-8.69%$14.9M
VBIOValion Bio Inc.$1.55-7.74%$3.0M
NXLNexalin Technology Inc.$2.64-21.43%$2.8M
NUWENuwellis Inc.$0.6210-7.36%$2.3M
ITOCiTonic Holdings Ltd$3.94+10.06%$28.8M
QTIQT Imaging Holdings Inc.$2.45-5.77%$35.9M
POCIPrecision Optics Corporation Inc.$4.56-0.98%$50.0M
ECORelectroCore Inc.$8.39-9.59%$75.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier